ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 112,33
0,25%
Dow Jones
39 671,04
-0,51%
DAX
18 733,50
0,28%
Brent Oil
81,535
0,01%
Bitcoin
69 490,07
0,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Y mAbs Therapeutics Inc (YMAB)

  7. Y mAbs Therapeutics Inc (YMAB) Actualités

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateHeureSourceTitreSymboleSociété
21/05/202422h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
07/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:YMABY mAbs Therapeutics Inc
07/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
07/05/202422h05GlobeNewswire Inc.Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
26/04/202413h05GlobeNewswire Inc.Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024NASDAQ:YMABY mAbs Therapeutics Inc
25/04/202422h05GlobeNewswire Inc.Y-mAbs to Present at 2024 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
14/03/202414h05GlobeNewswire Inc.Y-mAbs Therapeutics Announces Resignation of Chief Financial OfficerNASDAQ:YMABY mAbs Therapeutics Inc
07/03/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
04/03/202413h30GlobeNewswire Inc.Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of DirectorsNASDAQ:YMABY mAbs Therapeutics Inc
29/02/202423h04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:YMABY mAbs Therapeutics Inc
29/02/202422h05GlobeNewswire Inc.Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
16/02/202413h30GlobeNewswire Inc.Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024NASDAQ:YMABY mAbs Therapeutics Inc
06/02/202421h59Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:YMABY mAbs Therapeutics Inc
02/01/202422h05GlobeNewswire Inc.Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:YMABY mAbs Therapeutics Inc
13/12/202322h05GlobeNewswire Inc.Y-mAbs Therapeutics Added to the NASDAQ Biotechnology IndexNASDAQ:YMABY mAbs Therapeutics Inc
13/11/202322h05GlobeNewswire Inc.Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
08/11/202323h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
31/10/202312h05GlobeNewswire Inc.Y-mAbs to Announce Third Quarter 2023 Financial and Operating Results on November 13, 2023NASDAQ:YMABY mAbs Therapeutics Inc
18/10/202322h05GlobeNewswire Inc.Y-mAbs Names Michael Rossi as President and Chief Executive Officer and DirectorNASDAQ:YMABY mAbs Therapeutics Inc
18/10/202300h01Dow Jones NewsY-mAbs Therapeutics New Drug Application Gets FDA ClearanceNASDAQ:YMABY mAbs Therapeutics Inc
17/10/202322h05GlobeNewswire Inc.Y-mAbs Therapeutics Announces U.S. FDA Clearance of Investigational New Drug Application for CD38-SADANASDAQ:YMABY mAbs Therapeutics Inc
16/10/202322h05GlobeNewswire Inc.Y-mAbs Announces Publication in CancersNASDAQ:YMABY mAbs Therapeutics Inc
21/09/202322h05GlobeNewswire Inc.Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric OncologyNASDAQ:YMABY mAbs Therapeutics Inc
06/09/202322h05GlobeNewswire Inc.Y-mAbs to Participate at Upcoming Investor Conferences in SeptemberNASDAQ:YMABY mAbs Therapeutics Inc
10/08/202322h05GlobeNewswire Inc.Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
02/08/202322h05GlobeNewswire Inc.Y-mAbs to Participate at Upcoming Investor ConferencesNASDAQ:YMABY mAbs Therapeutics Inc
01/08/202322h05GlobeNewswire Inc.Y-mAbs to Announce Second Quarter 2023 Financial and Operating Results on August 10, 2023NASDAQ:YMABY mAbs Therapeutics Inc
10/06/202300h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
09/06/202323h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
26/05/202315h00GlobeNewswire Inc.Y-mAbs Announces Presentation of GD2-SADA Study at ASCONASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB

Dernières Valeurs Consultées

BIT
P1XVC5
NLBNPIT1XVC5 20991231 74...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés